Anzeige
Mehr »
Freitag, 20.03.2026 - Börsentäglich über 12.000 News
Drohnen statt Panzer: Beginnt hier der nächste Milliarden-Superzyklus?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von x3news

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
14:23Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
11:23M+S Hydraulic AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
08:22Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
DoCB First Investment Bank AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
DoSopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
MiShelly Group SE: Annual financial report
MiCB First Investment Bank AD: Sustainability information
MiSopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
DiCB First Investment Bank AD: Consolidated annual financial report
DiEurohold Bulgaria AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
MoAdvance Terrafund REIT: Other unregulated information
13.03.Telelink Business Services Group AD: Other unregulated information
13.03.Telelink Business Services Group AD: Other unregulated information
12.03.Telelink Business Services Group AD: Other unregulated information
11.03.Venus AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
11.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
10.03.Bulgarian Real Estate Fund REIT: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
10.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
10.03.IPO Growth AD: Other unregulated information
09.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
06.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
06.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
06.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
06.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
06.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014